Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 4/20 | 0.45 |
| ▸ | RELA | Q04206 | 2/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | GFER | P55789 | 1/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.38 |
| ▸ | APP | P05067 | 3/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12120252 | 1.00 | NFE2L2 (0.45) | NFE2L2RELAALOX5PTGS1PTGS2 | |
| SCHEMBL13807903 | 1.00 | NFE2L2 (0.45) | NFE2L2RELAALOX5PTGS1PTGS2 | |
| SCHEMBL18198856 | 1.00 | NFE2L2 (0.45) | NFE2L2RELAALOX5PTGS1PTGS2 | |
| SCHEMBL13308456 | 0.90 | NFE2L2 (0.50) | NFE2L2RELAALOX5PTGS1PTGS2 | |
| SCHEMBL13308475 | 0.89 | PTGS1 (0.40) | NFE2L2RELAALOX5PTGS1PTGS2 | |
| SCHEMBL16489726 | 0.88 | NFE2L2 (0.56) | NFE2L2RELAALOX5PTGS1PTGS2 | |
| SCHEMBL3629423 | 0.88 | NFE2L2 (0.56) | NFE2L2RELAALOX5PTGS1PTGS2 | |
| SCHEMBL10015739 | 0.88 | NFE2L2 (0.56) | NFE2L2RELAALOX5PTGS1PTGS2 | |
| SCHEMBL6764358 | 0.88 | CHRNA7 (0.46) | ALOX5MEN1KMT2ACA1GAA | |
| SCHEMBL20663990 | 0.88 | NFE2L2 (0.56) | NFE2L2RELAALOX5PTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10862047-B2 | Organic electroluminescent device | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2020-12-08 | — | — | US | disclosed |
| US-10658596-B2 | — | — | 2020-05-19 | — | — | US | disclosed |
| US-10381573-B2 | Light-emitting material, organic light-emitting device, and compound | KYULUX, INC. (JP) | 2019-08-13 | — | — | US | disclosed |
| US-20160380205-A1 | LIGHT-EMITTING MATERIAL, ORGANIC LIGHT-EMITTING DEVICE, AND COMPOUND | KYULUX, INC. (JP) | 2016-12-29 | — | — | US | disclosed |
| US-20160190478-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2016-06-30 | — | — | US | disclosed |
| US-20160190478-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10381573-B2 | Light-emitting material, organic light-emitting device, and compound | CRY1, CRY2, GLB1 | NFE2L2 386/4885RELA 747/4885ALOX5 2406/4885 |
| US-20160380205-A1 | LIGHT-EMITTING MATERIAL, ORGANIC LIGHT-EMITTING DEVICE, AND COMPOUND | CRY1, CRY2, GLB1 | NFE2L2 346/4885RELA 776/4885ALOX5 2251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.